tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
scPharmaceuticals downgraded to Hold from Buy at Maxim
PremiumThe FlyscPharmaceuticals downgraded to Hold from Buy at Maxim
2M ago
MannKind price target raised to $8 from $7 at RBC Capital
Premium
The Fly
MannKind price target raised to $8 from $7 at RBC Capital
2M ago
scPharmaceuticals downgraded to Hold from Buy at Craig-Hallum
Premium
The Fly
scPharmaceuticals downgraded to Hold from Buy at Craig-Hallum
2M ago
scPharmaceuticals Announces Merger with MannKind Corporation
PremiumCompany AnnouncementsscPharmaceuticals Announces Merger with MannKind Corporation
2M ago
MannKind to acquire scPharmaceuticals for up to $6.35 per share in cash
Premium
The Fly
MannKind to acquire scPharmaceuticals for up to $6.35 per share in cash
2M ago
MannKind to acquire scPharmaceuticals for up to $6.35 per share in cash
Premium
The Fly
MannKind to acquire scPharmaceuticals for up to $6.35 per share in cash
2M ago
Strong Market Presence and Strategic Advancements Drive Buy Rating for scPharmaceuticals
PremiumRatingsStrong Market Presence and Strategic Advancements Drive Buy Rating for scPharmaceuticals
2M ago
Strong Financial Performance and Strategic Initiatives Justify Buy Rating for scPharmaceuticals
Premium
Ratings
Strong Financial Performance and Strategic Initiatives Justify Buy Rating for scPharmaceuticals
2M ago
scPharmaceuticals Reports Strong Q2 2025 Growth
Premium
Company Announcements
scPharmaceuticals Reports Strong Q2 2025 Growth
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100